Copyright: ©Author(s) 2026.
World J Cardiol. Apr 26, 2026; 18(4): 115942
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.115942
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.115942
Table 1 Quantitative studies included in the final systematic review analysis (n = 14)
| Ref. | Country | Population/region | Design | Screening modality | Sample size | Primary outcome | Key findings/quantitative result |
| Corrado et al[26], 2006 | Italy | Competitive athletes, Veneto region | Prospective cohort | H&P + ECG (mandatory) | 42386 | SCD incidence | 89% SCD reduction (3.6/100000 to 0.4/100000 person-years) |
| Papadakis et al[25], 2011 | United Kingdom | Voluntary youth program | Prospective registry | H&P + ECG ± TTE | 32561 | Diagnostic yield | 0.4% serious cardiac findings; 80% detected by ECG |
| Harmon et al[1], 2016 | United States | HS and college athletes | Observational registry | H&P only | 2046000 | SCD incidence | 1.21/100000 person-years; low sensitivity (< 20 %) |
| Drezner et al[24], 2013 | United States | Collegiate athletes | Comparative | H&P vs ECG ± TTE | 11168 | Sensitivity/specificity | ECG 94%/93%; false positives < 5 % (Seattle criteria) |
| Leslie et al[30], 2012 | United States | Modeled athlete cohort | Economic model | ECG ± TTE vs H&P | Cost-effectiveness | 42000 dollars per life-year saved (ICER) | |
| Malhotra and Sharma[5], 2018 | United Kingdom | Elite adolescent athletes | Prospective 20-year follow-up | H&P + ECG | 11168 | Long-term SCD prevention | 0.38/100000 person-years; 80% of SCD etiologies identified |
| Wheeler et al[11], 2010 | United States | Modeled United State athletes | Economic simulation | H&P vs ECG ± ECHO | Cost per life saved | > 10 thousand dollars/life year saved (early); improved < 7 thousand dollars with newer criteria | |
| Steinvil et al[22], 2011 | Israel | National cohort | Retrospective trend | Mandatory ECG | National registry data over 12 years | SCD trend | No statistically significant SCD reduction |
| Baggish et al[15], 2017 | United States | Collegiate athletes | Mixed observational | H&P ± ECG | 510 | Diagnostic yield | 6 pathologies found only by ECG; cost per case approximately 11000 dollars |
| Moulson et al[33], 2021 | Canada | Multicenter athletes | Prospective pilot | H&P + ECG | 2120 | Feasibility/FP rate | FP 3.2%; supports international criteria use |
| Petek and Baggish[23], 2020 | United States | Sports-medicine clinicians | Survey-based quantitative | H&P ± ECG | 125 | Implementation feasibility | 68% cited training barriers; 72% favored ECG inclusion |
| Hernelahti et al[36], 2008 | Nordic | National registries | Policy analysis/quantitative comparison | H&P vs proposed ECG | Policy outcome | Cost-burden model > 150 thousand dollars/life year saved; ECG not adopted | |
| Dhutia et al[12], 2021 | United Kingdom | Health-policy review | Quantitative + ethical | H&P + ECG ± genetic | Cost/risk model | Supported selective screening in high-risk sports | |
| Asif et al[38], 2014 | United States | HS athletes ± parents | Mixed-methods (survey + rates) | H&P + ECG | 410 | Psychological/compliance data | 92% reported reassurance post-ECG; FP 4% |
- Citation: Celebi TB, Landman SM, Hayes JP, Makaryus AN. Electrocardiogram screening in adolescent athletes - evaluating clinical protocols, outcomes, and cost-effectiveness a systemic literature review. World J Cardiol 2026; 18(4): 115942
- URL: https://www.wjgnet.com/1949-8462/full/v18/i4/115942.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i4.115942